CVS Health (CVS) Tops Q2 EPS by 35c, Beats on Revenue; Offers FY25 EPS Guidance
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $102.81 -1.59%
EPS Growth %: +1.1%
Financial Fact:
Weighted average basic common shares outstanding (in shares): 1.07B
Today's EPS Names:
CCEL, SLP, TMQ, More
EPS Growth %: +1.1%
Financial Fact:
Weighted average basic common shares outstanding (in shares): 1.07B
Today's EPS Names:
CCEL, SLP, TMQ, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q2 EPS of $1.81, $0.35 better than the analyst estimate of $1.46. Revenue for the quarter came in at $98.9 billion versus the consensus estimate of $94.73 billion.
GUIDANCE:
CVS Health sees FY2025 EPS of $6.30-$6.40, versus the consensus of $6.12.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- WD-40 Co. (WDFC) Tops Q3 EPS by 76c; offers guidance
- AZZ, Inc. (AZZ) Tops Q1 EPS by 16c, Offers Guidance
- Key things to know ahead of SK Hynix’s blockbuster US listing
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
